Terms: = Gastric cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Staging
4 results:
1. Tumor-positive peritoneal cytology in patients with gastric cancer is associated with poor outcome: A nationwide study.
Van Der Sluis K; Taylor SN; Kodach LL; van Dieren JM; de Hingh IHJT; Wijnhoven BPL; Verhoeven RHA; Vollebergh MA; van Sandick JW
Eur J Cancer; 2024 Mar; 199():113541. PubMed ID: 38237371
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation.
Wang T; Wu Y; Zhou H; Wu C; Zhang X; Chen Y; Zhao D
BMC Gastroenterol; 2021 Jan; 21(1):38. PubMed ID: 33499821
[TBL] [Abstract] [Full Text] [Related]
3. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer?
Gertler R; Stein HJ; Loos M; Langer R; Friess H; Feith M
Am J Surg Pathol; 2011 Oct; 35(10):1512-22. PubMed ID: 21934477
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic performance of 64-channel multidetector CT in the evaluation of gastric cancer: differentiation of mucosal cancer (T1a) from submucosal involvement (T1b and T2).
Lee IJ; Lee JM; Kim SH; Shin CI; Lee JY; Kim SH; Han JK; Choi BI
Radiology; 2010 Jun; 255(3):805-14. PubMed ID: 20501718
[TBL] [Abstract] [Full Text] [Related]
